Medical devices offered for import are reviewed for establishment registration, device listing, premarket authorization status, labeling, and other applicable requirements. The exact pathway depends on device classification, intended use, technological characteristics, and whether the product requires 510(k) clearance, De Novo authorization, premarket approval, or is exempt.
Foreign manufacturers generally need to identify a U.S. agent and maintain current establishment registration and device listing information. Entry data must accurately identify the manufacturer, importer, product code, and applicable premarket submission number or exemption.
Labeling and promotional claims must match the legally marketed intended use. A product presented as a general wellness item in one country may qualify as a medical device in the United States if its claims indicate diagnosis, cure, mitigation, treatment, or prevention of disease.
Before shipment, manufacturers should confirm classification, registration and listing status, U.S. agent information, premarket pathway, labeling, and import-entry data. Misalignment among these elements can result in holds, requests for information, detention, or refusal.
APEX CS practical takeaway: Confirm the product-specific regulatory pathway before production, testing, labeling, or shipment. Requirements vary by device design, intended use, claims, market channel, and final configuration.